Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Using points for maximum value experiences can elevate your lifestyle. Learn how to leverage your rewards for unforgettable moments.
23,434 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
When relationships hit turbulence in the public eye, money often becomes the quiet crisis. This article translates th...
The U.S. Postal Service has filed for an 8% temporary price increase on Priority Mail and other core services to offs...
A Colorado meatpacking strike enters its second week, marking the first major labor action at a U.S. meat plant in de...
Israel launched airstrikes on Iran’s nuclear facilities, drawing Iran’s vow of retaliation and sending tremors throug...
Morgan Stanley halves Lucid's price target to $5, keeping an Underweight rating as production stoppages and a leaders...
In a notable policy reversal, the Trump administration is weighing an executive order to create a government-industry...
As investors retire or near retirement, the tax treatment of dividend income matters as much as the yield. This expla...
A new NRMLA webinar explores how caregiving and intergenerational concerns influence reverse mortgage choices, offeri...
Daiwa upgrades Qualcomm to Outperform, increasing the target to $225 as analysts forecast a broader AI infrastructure...
Elon Musk publicly backs Warren Buffett's iconic debt plan, calling it 'this way' as Washington grapples with a loomi...
The semiconductor market could double by 2030 as AI, data centers, and EVs push demand higher. This guide breaks down...